Find out how ICT can support biomedical and clinical researchFind out more. From Clever cars to clever farms... Embedded Systems
Business Development

Business Development

NICTA’s Business Development activities are integrated into the research process from developing a concept to realising an outcome.

Early-stage commercialisation activity in NICTA projects focuses on understanding the target market and identifying customers and/or industry partners.

Commercialisation activity becomes more structured when the project team’s focus shifts to include a substantial commercial outcome. At this stage, the Board Commercialisation Committee and NIPR may provide additional resources. At NICTA, there are two main paths to commercialisation: licensing or spinning out a company.

Funding

NICTA offers generous financial support to research projects which show potential to deliver commercial impact.

By the end of June 2007, NICTA had provided NIPR with a substantial commercialisation fund. This fund is used to provide:

  • Market Validation Grants – by the end of July 2007, 12 Market Validation Grants were awarded to NICTA research projects
  • Commercialisation Development Investments – by the end of June 2007, two Commercialisation Development Investments were awarded to NICTA research projects
  • Launch Co-Investments
  • Other commercialisation investments or costs approved by the Board Commercialisation Committee.

NICTA may provide a total cash investment per project of up to $500,000 through this process – provided the investment is consistent with NIPR's fund’s prudential guidelines. This sum includes grants to the NICTA project and investments in any commercialisation vehicle (including a spin-out company).